Ed. Note: Sara Gorman will be joining us once a month to highlight different aspects of her forthcoming book on science denialism. Have you ever Read More
Let’s face it, after more than eight years leading PATH’s work on developing vaccines against Shigella and enterotoxigenic Escherichia coli (ETEC) and more than three decades of working on enteric diseases, you might assume that I’ve heard it all when it comes to diarrhea. Not in the least! read more
The US National Institutes of Health announced that it is expanding an early-stage HIV vaccine clinical trial in South Africa due to very promising early results. The new study, called HVTN 702, is designed to determine whether the regimen is safe, tolerable and effective at preventing HIV infection among South African adults. The trial is
Project Syndicate: The Right Diet for Gender Equality Ngozi Okonjo-Iweala, chair of the Global Alliance for Vaccines and Immunization, and Lawrence Haddad, lead author of the upcoming 2016 Global Nutrition Report “…We can no longer treat gender discrimination and malnutrition as separate issues. The two are inextricably linked; they reinforce each other in a pattern…More
New York Times: Eliminate the TB Scourge Uvistra Naidoo, pediatrician and research scientist “…Today we have an ineffective TB vaccine, insufficient diagnostic tools, TB drugs with pernicious side effects, a growing problem of bacterial resistance to current treatments, and an inexplicable lack of urgency, even though one-third of the planet’s population is infected by TB,…More
Cet article fait partie de la série d’articles #ProtectingKids. Voir tous ces articles ici. Brian Atuhaire est l’officier de programme dans le département des équipements et matériels de PATH. Le Centre de Santé Bunaseke qui se trouve dans la plaine isolée du Mont Elgon en Ouganda a passé deux ans sans réfrigérateur. Cela peut sembler anodin […] ; ; ; ;Related StoriesA refrigerator can save a life: improving the supply chain to protect African kidsPolio, pride, and love: the story of an exceptional mother and her sonKeeping a promise to mothers and children ;
Publication date: June 2016 Source:Social Science & Medicine, Volume 159 Author(s): Jennifer L.
Publication date: June 2016 Source:Social Science & Medicine, Volume 159 Author(s): Kayoll V.
Publication date: June 2016 Source:Social Science & Medicine, Volume 159 Author(s): Jeremy K.
Asia’s first dengue vaccine has been distributed in a mass school-based immunization program ;in the Philippines. So far, the program appears to be running without difficulties, but some health professionals are concerned that the vaccine was released ;before researchers could ensure ;its long-term safety. From the beginning, the vaccine’s French manufacturer Sanofi Pasteur has been concerned about a
Editor’s note: Post author Nanthalile Mugala, PATH’s program leader in Zambia, is speaking about Zambia’s efforts to eliminate malaria at PATH’s Breakfast for Global Health, which will be held on May 10 in Bellevue, Washington, and May 13 in Seattle. My country, Zambia, is about to release a bold plan to eliminate malaria by 2020—and […] ; ; ; ;Related StoriesThe battle against malaria gets a major data makeoverThe next great elimination story: malariaProtecting Kids: powerful stories of immunization from the field ;
The aim of this study is to examine the effects of ethnicity, disaggregating Asian Indian from other Asians, health insurance coverage, and nativity on influenza vaccination rates in the United States.
Reuters: Gates Foundation backs Takeda polio vaccine with $38 million grant “Japan’s Takeda Pharmaceuticals is to get $38 million from the Bill & Melinda Gates Foundation to develop a crucial, low-cost polio vaccine for use in developing countries. … Chris Elias, the Gates Foundation’s head of global development, said the partnership would help ‘ensure that…More